A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

AIMS: The aim of this study was to evaluate the haemodynamic effects of serelaxin (30 µg/kg/day 20-h infusion and 4-h post-infusion period) in patients with acute heart failure (AHF). METHODS AND RESULTS: This double-blind, multicentre study randomized 71 AHF patients with pulmonary capillary wedge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponikowski, Piotr, Mitrovic, Veselin, Ruda, Mikhail, Fernandez, Alberto, Voors, Adriaan A., Vishnevsky, Alexander, Cotter, Gad, Milo, Olga, Laessing, Ute, Zhang, Yiming, Dahlke, Marion, Zymlinski, Robert, Metra, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
FASTTrack Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924183/
https://www.ncbi.nlm.nih.gov/pubmed/24255129
http://dx.doi.org/10.1093/eurheartj/eht459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924183/
https://www.ncbi.nlm.nih.gov/pubmed/24255129
http://dx.doi.org/10.1093/eurheartj/eht459

Ejemplares similares